Regeneron Pharmaceuticals Inc (REGN)

Current ratio

		Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Total current assets	US$ in thousands	18,660,900	19,479,200	15,884,100	14,014,900	9,779,100
Total current liabilities	US$ in thousands	3,944,300	3,423,400	3,141,300	3,932,500	2,697,400
Current ratio		4.73	5.69	5.06	3.56	3.63

December 31, 2024 calculation

Current ratio = Total current assets ÷ Total current liabilities
= $18,660,900K ÷ $3,944,300K
= 4.73

The current ratio of Regeneron Pharmaceuticals Inc has been consistently healthy over the years, indicating the company's ability to meet its short-term obligations using its current assets. As of December 31, 2020, the current ratio was 3.63, slightly decreasing to 3.56 by December 31, 2021. However, there was a significant improvement in the ratio by December 31, 2022, reaching 5.06, which further increased to 5.69 by December 31, 2023. Although there was a slight decrease to 4.73 by December 31, 2024, the current ratio still remains at a level that indicates a strong liquidity position for Regeneron Pharmaceuticals Inc. This consistent trend suggests the company's ability to manage its short-term financial obligations effectively.